Reference drugs for triple combination test drug in Russia [Design Issues]

posted by Yura – Belarus, 2019-11-19 21:51 (374 d 23:14 ago) – Posting: # 20830
Views: 2,993

(edited by mittyri on 2019-11-19 22:50)

Hi Beholder,
There is no reason for the regulator not to want to check section 4.5 of the Guideline on clinical development of fixed combination medicinal products :|>
Kind regards,

Edit: Guideline linked. Also changed the name in signature to the usual one[Mittyri]

Complete thread:

 Admin contact
21,216 posts in 4,427 threads, 1,482 registered users;
online 16 (0 registered, 16 guests [including 14 identified bots]).
Forum time: Saturday 21:06 CET (Europe/Vienna)

Science may be described as the art of systematic over-simplification –
the art of discerning what we may with advantage omit.    Karl R. Popper

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz